Wave Life Sciences Ltd.

Healthcare · Biotechnology · Singapore

Last price 3.59 USD (Oct 30, 2026, 4:00 PM EDT) · Market cap 708.05M

Overview · Financial statements · Key statistics · Dividends · Company profile · Price history · Reports

Wave Life Sciences, Inc., a clinical-stage biotechnology company, focuses on unlocking the potential of ribonucleic acid (RNA) medicines to transform human health. Its RNA medicines platform, PRISM, combines RNA medicine modalities, chemistry innovation, and deep insights in human genetics to deliver scientific breakthroughs that treat rare and common disorders. Its pipeline focuses on obesity (WVE-007), alpha-1 antitrypsin deficiency (AATD) (WVE-006), and PNPLA3 I148M liver disease (WVE-008) programs; and clinical programs for Duchenne muscula...